RNA5SP310

Across TCGA pan-cancer cohorts, RNA5SP310 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated RNA5SP310 data layer.

The strongest signal is observed in testicular germ cell tumors (TGCT), where higher RNA5SP310 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNA5SP310 expression acts as an unfavorable survival marker, although some lineages such as SARC and LAML show a favorable association.

TGCT, THCA, and LIHC are the cancer types where RNA5SP310 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
TGCT	DFS	Tertile	II,III,IV	0.622	0.978	.016	54	view →
THCA	DFS	Tertile	All	0.895	0.954	.013	27	view →
LIHC	DFS	Tertile	II,III,IV	0.196	0.435	.005	27	view →
KICH	DFS	Quartile	All	0.724	0.940	.011	24	view →
COAD	OS	Tertile	All	0.693	0.830	.010	21	view →
SARC	OS	Tertile	All	0.822	0.427	.016	18	view →
LAML	DFS	Tertile	All	0.543	0.262	.011	18	view →
HNSC	OS	Tertile	IV	0.560	0.364	.017	15	view →
OV	DFS	Tertile	IV	0.298	0.519	.008	10	view →
ACC	DFS	Tertile	IV	0.145	0.435	.039	9	view →
PAAD	OS	Tertile	All	0.486	0.689	.008	9	view →
KIRC	DFS	Quartile	All	0.892	0.779	.006	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

RNA5SP310–TGCT (DFS)

Open the TGCT breakdown →